|
ISCA1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62436730732907E-12 |
| Normal-vs-Stage2 |
5.60229999999606E-05 |
| Normal-vs-Stage3 |
1.62436730732907E-12 |
| Normal-vs-Stage4 |
1.62447832963153E-12 |
| Stage1-vs-Stage2 |
3.678800E-01 |
| Stage1-vs-Stage3 |
4.221900E-02 |
| Stage1-vs-Stage4 |
2.25499999999546E-05 |
| Stage2-vs-Stage3 |
3.470400E-02 |
| Stage2-vs-Stage4 |
1.558110E-03 |
| Stage3-vs-Stage4 |
6.274100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
1.62458935193399E-12 |
| Normal-vs-Asian |
1.69707999999602E-05 |
| Caucasian-vs-AfricanAmerican |
9.757600E-02 |
| Caucasian-vs-Asian |
7.353200E-01 |
| AfricanAmerican-vs-Asian |
8.369800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62481139653892E-12 |
| Male-vs-Female |
1.345810E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.96309643488257E-11 |
| Normal-vs-Age(41-60Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
9.2519000016722E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.434400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.469600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.982440E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.552800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.881600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.599800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.66630000000479E-05 |
| Normal-vs-Grade 2 |
2.16493489801906E-14 |
| Normal-vs-Grade 3 |
<1E-12 |
| Normal-vs-Grade 4 |
1.62447832963153E-12 |
| Grade 1-vs-Grade 2 |
8.743400E-01 |
| Grade 1-vs-Grade 3 |
1.250760E-01 |
| Grade 1-vs-Grade 4 |
3.583000E-03 |
| Grade 2-vs-Grade 3 |
3.602900E-04 |
| Grade 2-vs-Grade 4 |
5.34820000508418E-08 |
| Grade 3-vs-Grade 4 |
6.797500E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.40305602878288E-12 |
| Normal-vs-ccB subtype |
<1E-12 |
| ccA subtype-vs-ccB subtype |
4.32589999999067E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62447832963153E-12 |
| Normal-vs-N1 |
1.427580E-04 |
| N0-vs-N1 |
1.401380E-01 |
|
|
